Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Description of Mouse IgG2a, kappa Isotype Control antibody (MOPC-173)

Introduction:

Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is a monoclonal antibody that is widely used in scientific research as a negative control for experiments involving mouse IgG2a antibodies. This antibody is derived from the MOPC-173 hybridoma cell line and is produced in vitro using hybridoma technology. It is a valuable tool for researchers studying the immune system and its response to various therapeutic targets.

Structure:

Mouse IgG2a, kappa Isotype Control antibody belongs to the immunoglobulin superfamily and is composed of two identical heavy chains and two identical light chains. The heavy chains consist of four constant domains (CH1-CH4) and one variable domain (VH), while the light chains consist of two constant domains (CL) and one variable domain (VL). The constant domains are responsible for the structural stability of the antibody, while the variable domains determine its specificity for antigens.

Activity:

As an isotype control, Mouse IgG2a, kappa Isotype Control antibody does not bind to any specific antigen. Instead, it mimics the binding properties of mouse IgG2a antibodies and can be used to determine the specificity of other antibodies in an experiment. This is because it has a similar structure and isotype as other mouse IgG2a antibodies, but lacks the ability to bind to any specific antigen. Therefore, any non-specific binding observed in an experiment can be attributed to the isotype control, and the results can be interpreted more accurately.

Application:

Mouse IgG2a, kappa Isotype Control antibody is widely used in various research applications, including flow cytometry, immunohistochemistry, and western blotting. In flow cytometry, it is used to distinguish between specific and non-specific binding of antibodies to cell surface markers. It is also used in immunohistochemistry to determine the specificity of primary antibodies for tissue samples. In western blotting, it is used as a negative control to ensure the specificity of primary antibodies for target proteins.

Therapeutic Target:

Mouse IgG2a, kappa Isotype Control antibody is not a therapeutic target itself, but it plays a crucial role in the development of therapeutic antibodies. Before a therapeutic antibody can be used in clinical trials, it must undergo rigorous testing to ensure its specificity and efficacy. Mouse IgG2a, kappa Isotype Control antibody is an essential tool in this process as it helps researchers determine the specificity of the therapeutic antibody and eliminate any non-specific binding.

Research Use:

Mouse IgG2a, kappa Isotype Control antibody is widely used in research to study the immune system and its response to various therapeutic targets. It is also used to validate the specificity of antibodies in experiments involving mouse models. Additionally, this antibody is used in the development and testing of new therapeutic antibodies, as well as in the quality control of existing therapeutic antibodies.

Conclusion:

In summary, Mouse IgG2a, kappa Isotype Control antibody (MOPC-173) is a valuable tool in scientific research for its ability to mimic the binding properties of mouse IgG2a antibodies. Its structure, activity, and application make it an essential component in experiments involving therapeutic targets and the development of therapeutic antibodies. As research in the field of immunology continues to advance, the use of this antibody will remain crucial in ensuring the accuracy and specificity of experimental results.